AIDS and HIV Infections

Group leader: José Antonio Iribarren, M.D., Ph.D.

Donostialdea IHO joseantonio.iribarrenloyarte@osakidetza.eus
Dr. José Antonio Iribarren Loyarte obtained his Degree in Medicine and Surgery from the University of the Basque Country (UPV/EHU) in 1981 and is a Doctor in Medicine from the same University in 1990, with special dedication to applied clinical research. He has been a member of the Aids Research Network since 2004 with continued financing since then. Dr. Iribarren is also Leader of the AIDS and HIV Infections Group of the Infectious Diseases Area of the Biodonostia HRI. He is the author or co-author of more than 290 articles published in PubMed and more than 30 chapters of books, the director of 2 doctoral theses and is currently directing another three, with special interest in clinical aspects and the treatment of HIV infection, emerging infections and infections in prosthetic devices.

Strategic Objectives

To improve the care provided to our patients through clinical research applied in a sustainable framework.

Lines of research

  • HIV
    • Effectiveness and efficiency of antiretroviral therapy (efficiency, virological failure, etc.).
    • New care modals.
    • Morbidity and mortality among the cohort.
    • Access to clinical trials.
  • HIV/HVC co-infection
    • Epidemiology.
    • Cirrhosis and its complications following sustained viral response.
  • Non-HIV infections
    • Infective endocarditis.
    • Prosthetic joint infection and other musculoskeletal infections.
    • Bacteraemia.
    • Sexually transmitted diseases. Pre-exposure treatment.
    • Access to clinical trials (Clostridium difficile, cellulitis, bacteraemia and other organ infections).
  • Non-HIV infections -COVID
    • Descriptive studies in the general population and in subpopulations (immunosuppressed).
    • Clinical prediction rules.
    • Access to clinical trials.
  • High-risk infectious diseases and organisation and training in High-Level Hospital Isolation Units (UAAN)

Team Members

Name Surname
Center E-mail
Ignacio Álvarez Rodríguez OSI Donostialdea ignacio.alvarezrodriguez@osakidetza.eus
Harkaitz Azkune Galparsoro OSI Donostialdea
Maria Jesús Bustinduy Odriozola OSI Donostialdea majesus.bustinduyodriozola@osakidetza.eus
Xabier Camino Ortiz De Barrón OSI Donostialdea xabier.caminoortizdebarron@osakidetza.eus
Miguel Angel Goenaga Sánchez OSI Donostialdea miguelangel.goenagasanchez@osakidetza.eus
Maialen Ibarguren Pinilla OSI Donostialdea maialen.ibargurenpinilla@osakidetza.eus
Xabier Kortajarena Urkola OSI Donostialdea xabier.kortajarenaurkola@osakidetza.eus
Francisco Rodríguez Arrondo OSI Donostialdea francisco.rodriguezarrondo@osakidetza.eus
Miguel Angel Von Wichmann De Miguel OSI Donostialdea miguelangel.vonwichmanndemiguel@osakidetza.eus

Scientific Output

ESTUDIO DEL METABOLISMO DE PACIENTES CON COVID PERSISTENTE MEDIANTE METABOLOMICA
Código: 2021333032/BD
Investigador Principal (IP): XABIER CAMINO ORTIZ DE BARRON
Entidad Financiadora: DEPARTAMENTO DE SALUD
Fecha de Inicio: 2021-01-01
Fecha de finalización: 2021-12-31
Importe Concedido: 20.003,69 €
ACCIONES DE APOYO A LOS GRUPOS DE TRABAJO E INICIATIVAS ESTRATÉGICAS DE RIS3 BIOCIENCIAS SALUD
Código: 2020444004/BD
Investigador Principal (IP): JULIO ARRIZABALAGA AGUIRREAZALDEGUI
Entidad Financiadora: DEPARTAMENTO DE SALUD
Fecha de Inicio: 2020-01-01
Fecha de finalización: 2020-12-31
Importe Concedido: 0,00 €
VALIDACION EXTERNA DE DOS MODELOS DE PREDICCION DE MALA EVOLUCION DE COVID-19
Código: 21BU201
Investigador Principal (IP): IGNACIO ALVAREZ RODRIGUEZ
Entidad Financiadora: DEPARTAMENTO DE SALUD
Fecha de Inicio: 2020-11-02
Fecha de finalización: 2022-06-30
Importe Concedido: 12.784,12 €
RETIC RED ESPAÑOLA DE INVESTIGACION EN SIDA-RIS-
Código: RD16/0025/0016
Investigador Principal (IP): JOSE ANTONIO IRIBARREN LOYARTE
Entidad Financiadora: ISCIII INSTITUTO DE SALUD CARLOS III
Fecha de Inicio: 2017-01-01
Fecha de finalización: 2022-12-31
Importe Concedido: 162.250,00 €
RED DE SIDA
Código: RD12/0017/0019
Investigador Principal (IP): JOSE ANTONIO IRIBARREN LOYARTE
Entidad Financiadora: ISCIII INSTITUTO DE SALUD CARLOS III
Fecha de Inicio: 2013-01-01
Fecha de finalización: 2017-12-31
Importe Concedido: 136.100,00 €